Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1Maike Janssen, Sascha Dietrich, Christian Rohde et al.|Blood|2022Cited by 100
The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3β inhibitionGabriele Varano, Stefano Casola, Simon Raffel et al.|Nature|2017Cited by 83